Loading...
EDAP TMS S.A.
EDAP•NASDAQ
HealthcareMedical - Devices
$1.81
$-0.01(-0.55%)
EDAP TMS S.A. (EDAP) Financial Performance & Statements
Review EDAP TMS S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.11%
↑ 6.11%
Operating Income Growth
-3.64%
↓ 3.64%
Net Income Growth
10.20%
↑ 10.20%
Operating Cash Flow Growth
7.45%
↑ 7.45%
Operating Margin
-32.03%
↓ 32.03%
Gross Margin
41.42%
↑ 41.42%
Net Profit Margin
-29.66%
↓ 29.66%
ROE
-41.35%
↓ 41.35%
ROIC
-42.61%
↓ 42.61%
EDAP TMS S.A. (EDAP) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for EDAP TMS S.A. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Net Income | -$1.94M | -$6.40M | -$6.13M | -$4.57M |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Income Tax | $0.00 | $0.00 | $0.00 | $0.00 |
| Stock Based Compensation | $0.00 | $0.00 | $0.00 | $692000.00 |
| Change In Working Capital | $299000.00 | -$69000.00 | -$1.65M | -$547202.00 |
| Accounts Receivables | $0.00 | $0.00 | $0.00 | $0.00 |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts Payables | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Working Capital | $299000.00 | -$69000.00 | -$1.65M | -$544000.00 |
| Other Non-Cash Items | $2.85M | $1.61M | $1.55M | $1.35M |
| Net Cash From Operating Activities | $1.21M | -$4.86M | -$6.23M | -$3.77M |
| Investments In Property Plant & Equipment | -$1.27M | -$979000.00 | $0.00 | -$1.10M |
| Acquisitions Net | $0.00 | $0.00 | $0.00 | $0.00 |
| Purchases Of Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Sales/Maturities Of Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Investing Activities | -$19000.00 | $0.00 | -$758266.00 | $0.00 |
| Net Cash Used For Investing Activities | -$1.29M | -$979000.00 | -$758266.00 | -$1.10M |
| Debt Repayment | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Issued | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Repurchased | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Financing Activities | $5.45M | $614000.00 | -$1.27M | -$167000.00 |
| Net Cash From Financing Activities | $5.45M | $614000.00 | -$1.27M | -$167983.00 |
| Effect Of Forex Changes On Cash | -$1.02M | $493000.00 | -$22000.00 | -$13000.00 |
| Net Change In Cash | $0.00 | $0.00 | -$8.26M | -$5.03M |
| Cash At End Of Period | $0.00 | $0.00 | $30.22M | $38.48M |
| Cash At Beginning Of Period | $0.00 | $0.00 | $38.48M | $43.51M |
| Operating Cash Flow | $1.21M | -$4.86M | -$6.19M | -$3.77M |
| Capital Expenditure | -$1.27M | -$979000.00 | -$756000.00 | -$1.10M |
| Free Cash Flow | -$57000.00 | -$5.84M | -$6.94M | -$4.88M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan